SCHEMBL29664328

SCHEMBL29664328

Nc1cccc(-c2cnn(-c3ccncc3)c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 2/20 0.50
MKNK2 Q9HBH9 2/20 0.50
MEN1 O00255 2/20 0.50
PSIP1 O75475 1/20 0.50
AXL P30530 1/20 0.50
CYP17A1 P05093 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP19A1 P11511 2/20 0.48
CYP11B1 P15538 2/20 0.48
CYP11B2 P19099 2/20 0.48
MELK Q14680 2/20 0.46
MAP4K4 O95819 5/20 0.44
GRM4 Q14833 1/20 0.43
MAOA P21397 1/20 0.42
NTRK1 P04629 2/20 0.41
PIK3CA P42336 1/20 0.41
FLT3 P36888 1/20 0.40
GRM5 P41594 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23144521 1.00 MKNK1 (0.50) MKNK1MKNK2MEN1PSIP1AXL
SCHEMBL23144535 0.88 MAOA (0.53) MKNK1MKNK2MEN1PSIP1AXL
SCHEMBL29664332 0.88 MAOA (0.53) MKNK1MKNK2MEN1PSIP1AXL
SCHEMBL23144559 0.85 MAOA (0.55) MKNK1MKNK2MEN1PSIP1AXL
SCHEMBL29664364 0.84 GRM4 (0.47) MKNK1MKNK2MEN1PSIP1AXL
SCHEMBL29664194 0.84 MAP4K4 (0.44) MKNK1MKNK2MEN1PSIP1AXL
SCHEMBL23144544 0.84 GRM4 (0.47) MKNK1MKNK2MEN1PSIP1AXL
SCHEMBL23144576 0.84 MAP4K4 (0.44) MKNK1MKNK2MEN1PSIP1AXL
SCHEMBL23144557 0.83 NTRK1 (0.57) MKNK1MKNK2MEN1PSIP1AXL
SCHEMBL29664342 0.83 NTRK1 (0.57) MKNK1MKNK2MEN1PSIP1AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114728909-A Composition for preventing or treating cancer comprising novel trifluoromethylphenylpyrazole derivative as active ingredient 韩国原子力医学院 2022-07-08 CN disclosed